Related Experiment Video
Updated: May 18, 2026
09:49
Routine Screening Method for Microparticles in Platelet Transfusions
Published on: January 31, 2018
A consistent approach to platelet transfusion in the NICU
Antonio Del Vecchio1, Mario Motta, Maurizio Radicioni
1Division of Neonatology, Neonatal Intensive Care Unit, Di Venere Hospital, Bari, Italy. delveccant@libero.it
Summary
Platelet transfusions are crucial for treating low platelet counts in neonatal intensive care units (NICUs). This review covers their use, benefits, risks, and the importance of adhering to transfusion guidelines for neonates.
Area of Science:
- Neonatal Medicine
- Hematology
- Pediatric Critical Care
Background:
- Thrombocytopenia is common in neonatal intensive care units (NICUs).
- Platelet transfusions are a primary treatment for neonatal thrombocytopenia.
- Transfusions are used for active bleeding or high bleeding risk in neonates.
Purpose of the Study:
- To summarize the rationale, benefits, and risks of platelet transfusions in neonates.
- To review product selection for neonatal platelet transfusions.
- To emphasize adherence to transfusion guidelines.
Main Methods:
- Literature review on neonatal platelet transfusion practices.
- Synthesis of current evidence regarding transfusion indications.
- Analysis of risks and benefits associated with neonatal platelet transfusions.
Main Results:
- Platelet transfusions are essential for managing thrombocytopenia in NICU settings.
- Careful consideration of transfusion product and adherence to guidelines are critical.
- Balancing benefits against risks is paramount in clinical decision-making.
Conclusions:
- Optimizing platelet transfusion strategies in neonates requires understanding indications, benefits, and risks.
- Adherence to established transfusion guidelines improves patient outcomes.
- Appropriate product selection enhances the efficacy of platelet therapy in neonates.
